Mersana Therapeutics
Price & Volume
Stats
See more52W Range | $0.54-$6.28 |
Market Cap | $76.4M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $34.8M |
Revenue Growth (YoY) | 63.7% |
Gross Profit (12 Mos) | -$113.4M |
Diluted EPS | -$0.60 |
News
See moreYahoo Finance • last year
15 Small-Cap Stocks with High Potential
Yahoo Finance • last year
Mersana Therapeutics Inc (MRSN) Reports Q3 2023 Financial Results
Yahoo Finance • last year
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
Yahoo Finance • last year
Mersana Therapeutics Announces Changes in Leadership
About
CEO | Dr. Martin H. Huber M.D. |
CFO | Mr. Brian C. DeSchuytner |
Address | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 123 |
